Search Results - "MORENO, Carol"
-
1
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
Published in Haematologica (Roma) (01-09-2022)“…iLLUMINATE is a randomized, open-label phase III study of ibrutinib plus obinutuzumab (n=113) versus chlorambucil plus obinutuzumab (n=116) as first-line…”
Get full text
Journal Article -
2
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
Published in Blood (09-05-2019)“…Ibrutinib, a once-daily oral inhibitor of Bruton tyrosine kinase, has greatly improved outcomes for patients with chronic lymphocytic leukemia (CLL). The phase…”
Get full text
Journal Article -
3
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
Published in Haematologica (Roma) (01-09-2018)“…Results of RESONATE-2 (PCYC-1115/1116) supported approval of ibrutinib for first-line treatment of chronic lymphocytic leukemia. Extended analysis of…”
Get full text
Journal Article -
4
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study
Published in Journal of medical Internet research (15-07-2020)“…Chronic kidney disease (CKD) is a major global health burden, and is associated with increased adverse outcomes, poor quality of life, and substantial health…”
Get full text
Journal Article -
5
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Published in Haematologica (Roma) (01-04-2018)“…MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic…”
Get full text
Journal Article -
6
Chronic lymphocytic leukemia and autoimmunity: a systematic review
Published in Haematologica (Roma) (01-05-2011)“…Chronic lymphocytic leukemia is frequently associated with immune disturbances. The relationship between chronic lymphocytic leukemia and autoimmune…”
Get full text
Journal Article -
7
Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease
Published in Journal of cardiovascular pharmacology and therapeutics (01-01-2024)“…Potassium-binders patiromer and sodium zirconium cyclosilicate (SZC) are approved to treat hyperkalaemia, which is frequently observed in chronic kidney…”
Get full text
Journal Article -
8
Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance
Published in Blood (02-12-2010)“…We analyzed prevalence, characteristics, clinical correlates, and prognostic significance of autoimmune cytopenia in patients with chronic lymphocytic…”
Get full text
Journal Article -
9
Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
Published in Journal of Experimental and Clinical Cancer Research (15-10-2021)“…Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by uncontrolled proliferation of B-cells and severe immune dysfunction…”
Get full text
Journal Article Book Review -
10
Identifying multiple causative genes at a single GWAS locus
Published in Genome research (01-12-2013)“…Genome-wide association studies (GWAS) are useful for nominating candidate genes, but typically are unable to establish disease causality or differentiate…”
Get full text
Journal Article -
11
Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients
Published in Clinical kidney journal (01-07-2021)“…Hyperkalemia is common among hemodialysis (HD) patients and has been associated with adverse clinical outcomes. Previous studies considered a single serum…”
Get full text
Journal Article -
12
CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia
Published in Cytometry. Part B, Clinical cytometry (01-03-2019)“…Background The diagnosis of CLL is supported by a typical morphology and immunophenotype and usually does not present difficulties. Nevertheless, some patients…”
Get full text
Journal Article -
13
PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
14
Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat
Published in Proceedings of the National Academy of Sciences - PNAS (02-09-2014)“…PLEKHA7 (pleckstrin homology domain containing family A member 7) has been found in multiple studies as a candidate gene for human hypertension, yet functional…”
Get full text
Journal Article -
15
FcγRIIb-BCR coligation inhibits BCR signaling in chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-01-2021)Get full text
Journal Article -
16
Transposon‐mediated transgenesis, transgenic rescue, and tissue‐specific gene expression in rodents and rabbits
Published in The FASEB journal (01-03-2013)“…Germline transgenesis is an important procedure for functional investigation of biological pathways, as well as for animal biotechnology. We have established a…”
Get full text
Journal Article -
17
Progress and prospects in rat genetics: a community view
Published in Nature genetics (01-05-2008)“…The rat is an important system for modeling human disease. Four years ago, the rich 150-year history of rat research was transformed by the sequencing of the…”
Get full text
Journal Article -
18
Zinc-finger nucleases: new strategies to target the rat genome
Published in Clinical science (1979) (06-07-2010)“…The importance of genetic laboratory models, such as mice and rats, becomes evident when there is a poor understanding of the nature of human disease. Many rat…”
Get more information
Journal Article -
19
-
20
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
Published in BMJ open (12-06-2023)“…IntroductionHyperkalaemia is common, life-threatening and often requires emergency department (ED) management; however, no standardised ED treatment protocol…”
Get full text
Journal Article